Recent research suggests lecanemab may be less effective in females, raising important questions for future Alzheimer’s drug ...

The latest drugs for Alzheimer's disease may add years of independence to the lives of patients, but possibly only for some.

McGill researchers found lecanemab may be less effective in women, prompting calls for more personalized treatment and ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

Since becoming only the second Alzheimer's-modifying drug to gain American Federal Drug Administration approval in 2023, ...

Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression of symptoms in people with early-onset Alzheimer's.

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

The drug, gantenerumab, was abandoned by its developers, but subsequent anti-amyloid drugs lecanemab ( Leqembi) and donanemab ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...